首页> 外文期刊>Journal of anxiety disorders >Pharmacological treatment of anxiety disorders: Current treatments and future directions
【24h】

Pharmacological treatment of anxiety disorders: Current treatments and future directions

机译:焦虑症的药理治疗:当前治疗方法和未来方向

获取原文
获取原文并翻译 | 示例
       

摘要

Modern pharmacological treatments for anxiety disorders are safer and more tolerable than they were 30 years ago. Unfortunately, treatment efficacy and duration have not improved in most cases despite a greater understanding of the pathophysiology of anxiety. Moreover, innovative treatments have not reached the Market despite billions of research dollars invested in drug development. In reviewing the literature on current treatments, we argue that evidence-based practice would benefit from better research on the causes of incomplete treatment response as well as the comparative efficacy of drug combinations and sequencing. We also survey two broad approaches to the development of innovative anxiety treatments:the continued development of drugs based on specific neuroreceptors and the pharmacological manipulation of fear-related memory. We highlight directions for future research, as neither of these approaches is ready for routine clinical use. (C) 2012 Elsevier Ltd. All rights reserved.
机译:与30年前相比,用于焦虑症的现代药物治疗更安全,更耐受。不幸的是,尽管对焦虑的病理生理学有了更多的了解,但在大多数情况下治疗效果和持续时间并未得到改善。此外,尽管在药物开发上投入了数十亿美元的研究资金,但创新疗法尚未进入市场。在回顾有关当前治疗方法的文献时,我们认为基于证据的实践将受益于对治疗反应不完全的原因以及药物组合和测序的相对疗效的更好的研究。我们还调查了开发创新性焦虑疗法的两种广泛方法:基于特定神经受体的药物的持续开发以及与恐惧相关的记忆的药理处理。我们强调了未来研究的方向,因为这两种方法都不适合常规临床使用。 (C)2012 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号